362 related articles for article (PubMed ID: 31998435)
1. The Multifarious Link between Cytochrome P450s and Cancer.
Alzahrani AM; Rajendran P
Oxid Med Cell Longev; 2020; 2020():3028387. PubMed ID: 31998435
[TBL] [Abstract][Full Text] [Related]
2. Role of xenobiotic metabolism in cancer: involvement of transcriptional and miRNA regulation of P450s.
Tamási V; Monostory K; Prough RA; Falus A
Cell Mol Life Sci; 2011 Apr; 68(7):1131-46. PubMed ID: 21184128
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome p450 and chemical toxicology.
Guengerich FP
Chem Res Toxicol; 2008 Jan; 21(1):70-83. PubMed ID: 18052394
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450s and cytochrome P450 reductase in the olfactory organ of the cotton leafworm Spodoptera littoralis.
Pottier MA; Bozzolan F; Chertemps T; Jacquin-Joly E; Lalouette L; Siaussat D; Maïbèche-Coisne M
Insect Mol Biol; 2012 Dec; 21(6):568-80. PubMed ID: 22984814
[TBL] [Abstract][Full Text] [Related]
5. Histone demethylases set the stage for cancer metastasis.
Cao J; Yan Q
Sci Signal; 2013 Apr; 6(273):pe15, 1-2. PubMed ID: 23633674
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome P450 polymorphisms as risk factors for steroid hormone-related cancers.
Friedberg T
Am J Pharmacogenomics; 2001; 1(2):83-91. PubMed ID: 12174676
[TBL] [Abstract][Full Text] [Related]
7. Expression of cytochrome P450 in tumor tissues and its association with cancer development.
Oyama T; Kagawa N; Kunugita N; Kitagawa K; Ogawa M; Yamaguchi T; Suzuki R; Kinaga T; Yashima Y; Ozaki S; Isse T; Kim YD; Kim H; Kawamoto T
Front Biosci; 2004 May; 9():1967-76. PubMed ID: 14977602
[TBL] [Abstract][Full Text] [Related]
8. Global transcriptome profiling and functional analysis reveal that tissue-specific constitutive overexpression of cytochrome P450s confers tolerance to imidacloprid in palm weevils in date palm fields.
Antony B; Johny J; Abdelazim MM; Jakše J; Al-Saleh MA; Pain A
BMC Genomics; 2019 May; 20(1):440. PubMed ID: 31151384
[TBL] [Abstract][Full Text] [Related]
9. Profiling cytochrome P450 expression in ovarian cancer: identification of prognostic markers.
Downie D; McFadyen MC; Rooney PH; Cruickshank ME; Parkin DE; Miller ID; Telfer C; Melvin WT; Murray GI
Clin Cancer Res; 2005 Oct; 11(20):7369-75. PubMed ID: 16243809
[TBL] [Abstract][Full Text] [Related]
10. Kinetic analysis of the activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by heterologously expressed human P450 enzymes and the effect of P450-specific chemical inhibitors on this activation in human liver microsomes.
Patten CJ; Smith TJ; Murphy SE; Wang MH; Lee J; Tynes RE; Koch P; Yang CS
Arch Biochem Biophys; 1996 Sep; 333(1):127-38. PubMed ID: 8806763
[TBL] [Abstract][Full Text] [Related]
11. The role of cytochrome P450 in tumour development and progression and its potential in therapy.
Murray GI
J Pathol; 2000 Dec; 192(4):419-26. PubMed ID: 11113857
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome P450: Polymorphisms and Roles in Cancer, Diabetes and Atherosclerosis.
Elfaki I; Mir R; Almutairi FM; Duhier FMA
Asian Pac J Cancer Prev; 2018 Aug; 19(8):2057-2070. PubMed ID: 30139042
[TBL] [Abstract][Full Text] [Related]
13. Novel extrahepatic cytochrome P450s.
Karlgren M; Miura S; Ingelman-Sundberg M
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):57-61. PubMed ID: 15987645
[TBL] [Abstract][Full Text] [Related]
14. Membrane topology and search for potential redox partners of colon cancer-specific cytochrome P450 2W1.
Guo J; Thiess S; Johansson I; Mkrtchian S; Ingelman-Sundberg M
FEBS Lett; 2016 Feb; 590(3):330-9. PubMed ID: 26787547
[TBL] [Abstract][Full Text] [Related]
15. Utility of recombinant cytochrome p450 enzymes: a drug metabolism perspective.
Tang W; Wang RW; Lu AY
Curr Drug Metab; 2005 Oct; 6(5):503-17. PubMed ID: 16248842
[TBL] [Abstract][Full Text] [Related]
16. Structure of cytochrome p450s and personalized drug.
Wang JF; Zhang CC; Chou KC; Wei DQ
Curr Med Chem; 2009; 16(2):232-44. PubMed ID: 19149574
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450: what have we learned and what are the future issues?
Guengerich FP
Drug Metab Rev; 2004 May; 36(2):159-97. PubMed ID: 15237850
[TBL] [Abstract][Full Text] [Related]
18. Mechanism-based inactivation of human cytochromes p450s: experimental characterization, reactive intermediates, and clinical implications.
Hollenberg PF; Kent UM; Bumpus NN
Chem Res Toxicol; 2008 Jan; 21(1):189-205. PubMed ID: 18052110
[TBL] [Abstract][Full Text] [Related]
19. Molecular and functional diversity of fungal cytochrome P450s.
Ichinose H
Biol Pharm Bull; 2012; 35(6):833-7. PubMed ID: 22687471
[TBL] [Abstract][Full Text] [Related]
20. Activation of procarcinogens by human cytochrome P450 enzymes.
Guengerich FP; Shimada T
Mutat Res; 1998 May; 400(1-2):201-13. PubMed ID: 9685642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
